BioTechGrid

Discovery of a fragile foundation Four years ago in GEN, Scripps Laboratories predicted that the clinical diagnostic industry was on…

Researchers are digging deeper into biology’s complexity. In preclinical research, the traditional in vivo models are simply not enough to…

Laurence Arnold, PhD Head of R&D Pelago Bioscience We’ve never had more data in drug discovery. Yet despite this explosion…

From small molecules and protein therapeutics to gene therapies, biotech industry players have placed their bets on a wide range…

Mass spectrometry (MS) has quietly undergone one of the most consequential evolutions in modern drug discovery. Once viewed primarily as…

Membrane-permeable cyclic peptide that inhibits the intracellular Keap1-Nrf2 protein-protein interaction. [Christian Heinis (EPFL)] Macrocyclic peptides are a promising drug modality that combine the oral convenience…

Sponsored content brought to you by Selecting and advancing drug candidates through discovery and development is a long, resource-intensive process.…

Sponsored content brought to you by In biomedical research, promising programs rarely collapse for lack of scientific ambition. More often,…

Sponsored content brought to you by The world of biologics is moving far beyond traditional monoclonal antibodies, and companies across…